At present, screening for cervical cancer is done mainly by reading Pap smears for abnormal cells. Although this subjective method has led to a decrease in incidence and mortality attributable to cervical cancer in developed countries, false-positive and false-negative screening results happen regularly. With the insight that infection with high-risk human papillomavirus (HPV) is obligatory for the development of cervical cancer, and the introduction of sensitive HPV testing methods, it was foreseen...